ChREBP is an essential transcription factor involved in hepatic stress that upregulates the ACLY, ACC-1, and FASN enzymes involved in hepatic de novo lipogenesis and, therefore, is a central factor in NAFLD [127,128]. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.